COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care. Dis Mon 2020 Sep;66(9):101057
Date
08/08/2020Pubmed ID
32758363Pubmed Central ID
PMC7381936DOI
10.1016/j.disamonth.2020.101057Scopus ID
2-s2.0-85088981936 (requires institutional sign-in at Scopus site) 1 CitationAbstract
Coronavirus disease-2019 (COVID-19) has caused a pandemic that has affected millions of people worldwide. COVID-19 is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and is spread by close contact and by respiratory droplets. It has also impacted different aspects of caring for people with kidney disease, including those with acute kidney injury (AKI), chronic kidney disease (CKD), those requiring kidney replacement therapy (KRT), and those with a kidney transplant. All of these patients are considered high risk. The lessons learned from the COVID-19 pandemic will hopefully serve to protect patients with kidney disease in a similar situation in the future.
Author List
Patel D, Truong T, Shah N, Colbert GB, Thomas B, Velez JCQ, Lerma EV, Hiremath SAuthor
Beje Thomas MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
HumansKidney Diseases
Nephrology
Renal Replacement Therapy
